Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.

American journal of obstetrics and gynecology - 1 Oct 2017

Halle Mari Kyllesø, Ojesina Akinyemi I, Engerud Hilde, Woie Kathrine, Tangen Ingvild Løberg, Holst Frederik, Høivik Erling, Kusonmano Kanthida, Haldorsen Ingfrid S, Vintermyr Olav K, Trovik Jone, Bertelsen Bjørn I, Salvesen Helga B, Krakstad Camilla

Abstract excerpt

BACKGROUND: Cervical cancer is a major health problem worldwide. Identification of effective clinicopathologic and molecular markers is vital to improve treatment stratification. OBJECTIVES: The purpose of this study was to validate a set of well-defined clinicopathologic features in a large population-based, prospectively collected cervical cancer cohort to support their use in the clinic. Further, we explored...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Genes, erbB-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human papillomavirus 16

Share to Human papillomavirus 18

Share to Neuroendocrine Tumors

Share to Receptor, ErbB-2

Share to Sequence Analysis

Share to Tissue Array Analysis

Source

Identifiers

PMID: 28599900
DOI: 10.1016/j.ajog.2017.05.068

Genes

ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.PMID 28599900Read ↗

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.Semantic proximity Read ↗

Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.Semantic proximity Read ↗

Comprehensive Genomic Characterization of 102 Cervical Adenocarcinoma Tumors.Semantic proximity Read ↗

Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancerSemantic proximity Read ↗

Cervical Carcinoma: Oncobiology and BiomarkersSemantic proximity Read ↗

An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.Semantic proximity Read ↗

Integrated genomic and molecular characterization of cervical cancer.Semantic proximity Read ↗

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significanceSemantic proximity Read ↗

LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) PhenotypeSemantic proximity Read ↗

Molecular Differences Between Squamous Cell Carcinoma and Adenocarcinoma Cervical Cancer Subtypes: Potential Prognostic BiomarkersSemantic proximity Read ↗

Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.Semantic proximity Read ↗

ERBB2 mutation: A promising target in non-squamous cervical cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.